All News

As a comedic actress, Julia Sweeney can usually find the humor in just about any situation, but when diagnosed with cervical cancer, she felt more of a punch than a punchline. Learning that humor was her way of healing came soon afterward, though.

Not every cancer patient seeks, needs or wants a second opinion.

Talk with almost any cancer survivor, and he or she is likely to bring up the topic of "chemobrain," that fuzzy, murky state that patients blame for impaired memory. A review of the research shows how we're focusing on the problem.

ASCO has endorsed new prostate cancer survivorship care guidelines from the American Cancer Society that provide a structure to help prostate cancer patients with localized disease to receive high quality care from specialists and primary care physicians.

Scan anxiety haunts virtually every person dealing with cancer. Here are a few tips for managing the stress.

This Valentine's Day is extra special as our hearts are brimmed with happiness and our lives are filled with love. I recognize the courage and beauty it takes to live with cancer together.

Intimacy after a cancer diagnosis can be difficult due to emotional and physical side effects, but it can also be an important part of healing.

Information and advice about bone marrow transplants from the man who owns one

I went into dating after cancer with one goal, a decent date, and I got far more than I ever dreamed.

It's isolating to have cancer. Making a connection with someone who understands makes all the difference.

Richard Finn, of the Jonsson Comprehensive Cancer Center at UCLA and lead investigator of the PALOMA-1 study, explains the clinical implications of Ibrance's approval for hormone-positive, HER2-negative metastatic breast cancer.

With a deadline of April 14, the FDA will soon make its final approval decision on lenvatinib as a treatment for patients with progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC).

Immunotherapies have strong potential as a treatment option for patients with NSCLC, as clinical trials have shown dramatic and durable results.

Ixazomib, also known as MLN9708, met its primary endpoint of improving progression-free survival at an interim analysis of a phase 3 trial of relapsed or refractory multiple myeloma.

The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.

At least 10 vaccine candidates have entered advanced testing phases on the strength of impressive early stage results.

Medicare will immediately cover lung cancer screening with low-dose computed tomography (LDCT) for high-risk individuals, including current and former smokers, according to a national coverage determination (NCD) released by CMS.

We have all heard that personalized medicine holds great promise for cancer treatment, but what does it really mean?

My goal is to educate doctors around the globe about helping to diagnose Lynch syndrome and to continue to help patients who need support.

Thanks to The Cancer Genome Atlas (TCGA) Research Network, researchers now have a better understanding of genomic alternations in head and neck cancers.

Issues of fertility, body image and sexuality are all important when treating a young adult with cancer, yet many facilities lack proper utilities and training to assist this group of patients, which is why Anne Katz wrote the book, "This Should Not Be Happening: Young Adults with Cancer."

On the evolving role of PARP inhibitors in the treatment of ovarian cancer, Donna McNamara, co-chief of Gynecological Oncology at the John Theurer Cancer Center (JTCC), discusses the impact of these studies and the outlook going forward.

There's a list of things we're supposed to do as good patients. And then, there's the reality of living with cancer and doing the best we can.

Women diagnosed with early-stage breast cancer have a variety of decisions to make regarding treatment, but it's important for patients to realize all of their options when making those medical decisions.

In which Kevin introduces himself, catches the world up to date on his cancer battle, and sprinkles in some random bits of wisdom

A phase 3 study of Gazyva in indolent non-Hodgkin lymphoma has been stopped early after an interim analysis found the drug improved progression-free survival.

Each year on Feb. 4, people from around the world recognize World Cancer Day, an initiative to increase awareness of the global burden of cancer and promote strategies for reducing cancer incidence and death rates.

The anticipated approval of Ibrance (palbociclib) came two months ahead of expectations, as the FDA granted an accelerated approval to the drug as a frontline treatment for women with ER-positive, HER2-negative metastatic breast cancer.